LAB FY 2022 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$98M-25.0% YoY

Gross Profit

$37M37.8% margin

Operating Income

-$116M-118.6% margin

Net Income

-$190M-194.1% margin

EPS (Diluted)

$-2.43

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$93M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$390M

Total Liabilities

$472M

Stockholders' Equity

-$81M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$98M	$131M	-25.0%
Gross Profit	$37M	$69M	-46.6%
Operating Income	-$116M	-$67M	-72.3%
Net Income	-$190M	-$59M	-220.9%